Chronic kidney disease is a progressive disease with no cure and high morbidity and
mortality that occurs commonly in the general adult population, especially in people with …

Cardiovascular disease (CVD) is a major cause of death in patients with chronic kidney
disease (CKD). Both conditions are rising in incidence as well as prevalence, creating poor …

Cardiovascular (CV) disease remains an important cause of morbidity and mortality for
patients with chronic kidney disease (CKD). Although clustering of traditional risk factors with …

Background Hyperphosphatemia is associated with increased fibroblast growth factor 23
(FGF23), arterial calcification, and cardiovascular mortality. Effects of phosphate-lowering …

Vascular calcification (VC) is associated with increased cardiovascular risks in patients with
chronic kidney disease (CKD). Sodium-glucose cotransporter 2 inhibitors, such as …

Chronic kidney disease (CKD) is frequently accompanied by hyperphosphatemia. High
serum phosphate usually requires dietary measures, adequate dialysis prescription and/or …

Chronic kidney disease is a devastating condition resulting from irreversible loss of nephron
numbers and function and leading to end-stage renal disease and mineral disorders …

Chronic kidney disease (CKD) is associated with excess cardiovascular morbidity and
mortality compared to the general population. Hyperphosphataemia, associated with …

Context Higher fibroblast growth factor-23 (FGF23) concentrations are associated with heart
failure and mortality in diverse populations, but the strengths of associations differ markedly …

Arterial stiffness in chronic kidney disease: a modifiable c... : Current Opinion in Nephrology
and Hypertension Arterial stiffness in chronic kidney disease: a modifiable cardiovascular risk …